Rodman David Malcom Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$3.47M

Insider Activity of Rodman David Malcom

According to the SEC Form 4 filings, Rodman David Malcom, being in a position of

  1. Chief Medical Officer at Mineralys Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 427348 shares for $13.87M,
    over all time since 2023-08-10, has bought 0 shares, and sold 743624 shares for $18.85M.

Biography of Rodman David Malcom

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $13,870,65832100

Comparison of Insiders on Amount of Buys and Sells

2026-08-10SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
2,170
0.0026%
$27.09$58,785-6.37%
2026-07-17SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
416
0.0006%
$26.53$11,036-4.21%
2026-07-15SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
6,349
0.0093%
$26.61$168,955-4.69%
2026-07-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
14,058
0.0212%
$27.58$387,717-5.51%
2026-07-09SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
2,171
0.0034%
$30.30$65,781-9.74%
2026-06-17SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
4,584
0.0072%
$25.00$114,600+4.83%
2026-06-15SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
9,890
0.0148%
$23.81$235,487+10.12%
2026-06-12SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
6,349
0.0096%
$23.93$151,901+11.52%
2026-06-10SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
2,170
0.0034%
$25.00$54,250+10.23%
2026-05-18SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
417
0.0007%
$27.55$11,488-0.19%
2026-05-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
14,056
0.0207%
$28.58$401,789-1.92%
2026-05-12SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
6,348
0.0096%
$29.36$186,348-9.95%
2026-05-11SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
2,171
0.0033%
$29.71$64,500-11.3%
2026-04-17SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
416
0.0006%
$31.33$13,033-12.7%
2026-04-15SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
6,348
0.0097%
$27.66$175,586-12.2%
2026-04-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
14,058
0.0207%
$26.54$373,087-1.4%
2026-04-09SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
2,170
0.0032%
$27.38$59,415-1.44%
2026-03-17SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
417
0.0006%
$25.65$10,696+6.69%
2026-03-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
14,058
0.0213%
$26.26$369,225+1.81%
2026-03-12SaleMineralys Therapeutics, Inc.
MLYS
Chief Medical Officer
6,348
0.0097%
$27.37$173,748-1.26%
Total: 46
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.